Search
for
Sort by
Research 301–330 of 1000+
- Hyperandrogenism from an Ovarian Interstitial-Cell Tumor in an Alpaca
- Intrinsic versus Extrinsic Aging: A Histopathological, Morphometric and Immunohistochemical Study of Estrogen Receptor β and Androgen Receptor
- Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men
- Chapter 23. Therapeutic Control of Androgen Action
- COVID‐19, androgens, and androgenic alopecia
- Androgen Receptor Ligands: Agonists and Antagonists
- Hormonal Treatment for Skin Androgen-Related Disorders
- Modelling androgen synthesis and action during human sexual differentiation
- Alterations in androgen conjugate levels in women and men with alopecia
- The promoter of an androgen dependent gene in the hamster flank organ
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Identification of androgen-regulated genes in SV40-transformed human hair dermal papilla cells
- Androgens in SARS-CoV-2 Coronavirus Infections
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Androgen excess: a hallmark of polycystic ovary syndrome
- Androgen deprivation therapy and hormonal status in men with COVID-19
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome